STOCK TITAN

ParkerVision (PRKR) registers 18.0M shares for resale; $180K possible proceeds

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

ParkerVision, Inc. files a prospectus supplement registering 18,014,164 shares of Common Stock for resale by selling stockholders.

The shares comprise convertible-note conversions, consulting issuances and a warrant; the company will not receive proceeds from resales, except it would receive up to $180,000 if the Park Consulting Warrant is exercised for cash. The supplement incorporates an attached Form 8-K describing a director resignation and appointment.

Positive

  • None.

Negative

  • None.

Insights

Resale registration of 18,014,164 shares; proceeds mainly to selling holders.

The prospectus supplement registers 18,014,164 shares of Common Stock for resale by selling stockholders, including conversion shares from two tranches of convertible notes, shares issued for consulting services, and warrant shares. The filing states the company will not receive proceeds from those resales.

Only the Park Consulting Warrant, if exercised for cash, would generate up to $180,000 for corporate working capital. The supplement incorporates a Form 8-K that reports a director resignation and a new director appointment.

Board change disclosed: one retirement and one appointment.

The Form 8-K appended to the supplement discloses the resignation of director Lewis Titterton due to retirement and the unanimous appointment of Anthony Bowers to the Board and to its Audit and Compensation Committees. Compensation follows standard non-employee director arrangements and an indemnification agreement.

These are routine governance updates; the filing states there were no disagreements with management and no related transactions requiring Item 404 disclosure.

Registered shares 18,014,164 shares Prospectus Supplement dated May 21, 2026
Tranche 1 conversion shares 5,457,583 shares Conversion of Tranche 1 Notes at $0.10 per share
Tranche 2 conversion shares 10,131,581 shares Conversion of Tranche 2 Notes at $0.08 per share
Consulting shares 625,000 shares Issued for services under Fisher Consulting Agreement
Warrant shares 1,800,000 shares Five-year Park Consulting Warrant exercisable at $0.10 per share
Potential gross proceeds from warrant $180,000 If Park Consulting Warrant exercised for cash
resale by selling stockholders regulatory
"permits the resale by the selling stockholders listed in the Prospectus"
convertible promissory notes (Tranche 1/2) financial
"issuable upon conversion of, and for the payment of interest from time to time at our option, for convertible promissory notes"
Park Consulting Warrant financial
"issuable upon exercise of a five-year warrant with an exercise price of $0.10 per share"
prospectus supplement regulatory
"This Prospectus Supplement relates to the prospectus dated September 11, 2019"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Offering Type resale/secondary
Use of Proceeds Proceeds from any cash exercise of the Park Consulting Warrant would be used for general working capital and corporate purposes

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does ParkerVision's (PRKR) prospectus supplement register?

It registers 18,014,164 shares of Common Stock for resale by selling stockholders. The registration covers conversion shares from two note tranches, consulting shares, and shares issuable upon exercise of a warrant.

Will ParkerVision receive proceeds from the registered resale of shares?

No, the company will not receive proceeds from sales by the selling stockholders. If the Park Consulting Warrant is exercised for cash, the company would receive up to $180,000 in gross proceeds.

What are the sources of the 18,014,164 registered shares?

The registration includes up to 5,457,583 shares from Tranche 1 note conversions, 10,131,581 shares from Tranche 2 note conversions, 625,000 consulting shares, and 1,800,000 warrant shares.

What corporate governance change is disclosed in the attached Form 8-K?

The Form 8-K reports the retirement resignation of director Lewis Titterton and the Board's unanimous appointment of Anthony Bowers, who joined the Audit and Compensation Committees and will receive standard non-employee director compensation.

How would ParkerVision use proceeds from any warrant exercise?

Any proceeds from a cash exercise of the Park Consulting Warrant—up to $180,000—are expected to be used for general working capital and corporate purposes, as stated in the prospectus supplement.

Filed pursuant to Rule 424(b)(3)

Registration No. 333-233390

 

PROSPECTUS SUPPLEMENT No. 81

(to Prospectus dated September 11, 2019)

 

PARKERVISION, INC.

18,014,164 Shares of Common Stock

 

This Prospectus Supplement relates to the prospectus dated September 11, 2019, as amended and supplemented from time to time (the “Prospectus”) which permits the resale by the selling stockholders listed in the Prospectus of up to 18,014,164 shares of our common stock, par value $0.01 per share (“Common Stock”) consisting of (i) up to 5,457,583 shares of Common Stock issuable upon conversion of, and for the payment of interest from time to time at our option, for convertible promissory notes dated June 7, 2019 through July 15, 2019 which have a fixed conversion price of $0.10 per share (the “Tranche 1 Notes”), (ii) up to 10,131,581 shares of Common Stock issuable upon conversion of, and for the payment of interest from time to time at our option, for convertible promissory notes dated July 18, 2019 which have a fixed conversion price of $0.08 per share (the “Tranche 2 Notes”), (iii) up to 625,000 shares of Common Stock issued as payment for services in conjunction with a consulting agreement dated June 7, 2019 (the “Fisher Consulting Agreement”) and (iv) up to 1,800,000 shares of Common Stock issuable upon exercise of a five-year warrant with an exercise price of $0.10 per share, subject to adjustment and issued as payment for services in conjunction with a consulting agreement dated July 22, 2019 (the “Park Consulting Warrant”).

 

We will not receive proceeds from the sale of the shares of Common Stock by the selling stockholders. To the extent the Park Consulting Warrant is exercised for cash, we will receive up to an aggregate of $180,000 in gross proceeds. We expect to use proceeds received from the exercise of the Park Consulting Warrant, if any, for general working capital and corporate purposes.

 

This Prospectus Supplement is being filed to update and supplement the information previously included in the Prospectus with the information contained in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on May 21, 2026.  Accordingly, we have attached the 8-K to this prospectus supplement.  You should read this prospectus supplement together with the prospectus, which is to be delivered with this prospectus supplement.

 

Any statement contained in the Prospectus shall be deemed to be modified or superseded to the extent that information in this Prospectus Supplement modifies or supersedes such statement.  Any statement that is modified or superseded shall not be deemed to constitute a part of the Prospectus except as modified or superseded by this Prospectus Supplement.

 

This Prospectus Supplement should be read in conjunction with, and may not be delivered or utilized without, the Prospectus.

 

Our Common Stock is listed on the OTCQB Venture Capital Market under the ticker symbol “PRKR.” 

 

Investing in our securities involves a high degree of risk. See Risk Factors beginning on page 5 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

 

Neither the SEC nor any such authority has approved or disapproved these securities or determined whether this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

The date of this Prospectus Supplement is May 21, 2026.

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 15, 2026

 

PARKERVISION, INC.

(Exact Name of Registrant as Specified in Charter)

     

Florida

000-22904

59-2971472

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

   

4446-1A Hendricks Avenue Suite 354, Jacksonville, Florida

32207

(Address of Principal Executive Offices)

(Zip Code)

 

(904) 732-6100

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

None

 

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.

 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 

 

 

Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On May 15, 2026, Mr. Lewis Titterton resigned from the Board of Directors (the “Board”) of ParkerVision, Inc. (the "Company"), and from the Audit and Compensation Committees on which he served.  Mr. Titterton’s resignation was due to retirement and not due to any disagreement with the Company or any matter relating to the Company's operations, policies or practices. 

 

On May 19, 2026, the Board unanimously appointed Anthony Bowers to fill the director vacancy created by Mr. Titterton’s resignation.  Mr. Bowers was also appointed to the Audit and Compensation Committees of the Board.

 

Mr. Bowers, age 69, has served as Director of Corporate Sales at Intro-act, LLC since 2017.  Prior to joining Intro-act, LLC, Mr. Bowers held positions in corporate and institutional sales, including leadership roles at OTR Global and Goldman Sachs.  Mr. Bowers holds an MBA in Accounting and Finance from the Wharton School and a bachelor's degree in economics from Amherst College. 

 

There are no arrangements or understandings between Mr. Bowers and any other persons pursuant to which he was selected as a director.  There are no transactions involving Mr. Bowers requiring disclosure under Item 404(a) of Regulation S-K.

 

Mr. Bowers will receive the Company's standard non-employee director compensation arrangements.  The Company entered into its standard indemnification agreement with Mr. Bowers.

 

The Company issued a press release announcing the resignation of Mr. Titterton and the appointment of Mr. Bowers, a copy of which is furnished herewith as Exhibit 99.1.

 

 

 Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit

Description

99.1 Press Release dated May 21, 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

Dated: May 21, 2026

   
   

PARKERVISION, INC.

     
   

By /s/ Cynthia French

   

Cynthia French

   

Chief Financial Officer